BARA
Founder, Chair and Director
Miss Greta Peciulyte, MSc, MD, FEBU (GMC 7539240)

Miss Greta Peciulyte
Founder & Director
Miss Greta Peciulyte is a London-based urologist and regenerative andrologist with a professional focus on men’s sexual health, reproductive medicine, regenerative approaches and clinical education. She is a member of The British Association of Urological Surgeons (BAUS), European Association of Urology (EAU), European Society for Sexual Medicine (ESSM), and European Andrology Academy (EAA).
She completed an MSc in Cosmetic Science at the University of Chichester, UK, successfully defending her master’s thesis dissertation, entitled “Multi-Molecular Weight Hyaluronic Acid Systems in Cosmetic Science”. She is also a Clinical and Scientific Advisor (Urology) for Swiss biotechnology and tissue engineering company Regen Lab SA. She serves as Medical Director of Androfill and as a specialist in the formulation and quality of Androfill medical devices, including hyaluronic acid fillers and related products.
Miss Greta Peciulyte is a strategic advisor for a health-tech startup Quareb which bridges virtual psychosexual therapy consultations and AI enabled self-help application in a culturally sensitive approach.
​
Miss Greta Peciulyte has been pioneering regenerative andrology in her clinical practice on Harley Street, London, since 2018. She has remained deeply committed to contributing to the field and supporting its continued advancement.
​
Miss Greta Peciulyte aims to commence a PhD in Regenerative Andrology at the University of Lübeck, Germany, further strengthening her academic contribution to the field.
She founded The British Association of Regenerative Andrology to create an independent professional and scientific platform for education, research, multidisciplinary collaboration and responsible clinical innovation in this emerging field.
Her work brings together clinical practice, scientific education, translational research and professional governance, with a particular interest in evidence-informed regenerative treatments, patient safety and the development of credible standards in andrology.
